Henry Schein (NASDAQ:HSIC) Price Target Raised to $90.00 at Barrington Research

Henry Schein (NASDAQ:HSIC - Free Report) had its price objective hoisted by Barrington Research from $82.00 to $90.00 in a report published on Thursday morning,Benzinga reports. They currently have an outperform rating on the stock. Barrington Research also issued estimates for Henry Schein's Q1 2025 earnings at $1.06 EPS, Q2 2025 earnings at $1.20 EPS, Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $4.85 EPS.

Several other analysts also recently weighed in on the stock. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Finally, Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $80.10.

Henry Schein Stock Performance

NASDAQ HSIC traded down $0.25 during trading hours on Thursday, reaching $79.75. The company's stock had a trading volume of 1,041,915 shares, compared to its average volume of 1,360,455. The stock has a market cap of $9.94 billion, a PE ratio of 32.84, a PEG ratio of 2.21 and a beta of 0.91. The business has a 50-day simple moving average of $73.41 and a 200 day simple moving average of $71.46. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the firm posted $1.32 EPS. The business's revenue for the quarter was up .4% compared to the same quarter last year. Equities research analysts predict that Henry Schein will post 4.76 earnings per share for the current fiscal year.

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.14% of the company's stock.

Institutional Trading of Henry Schein

Hedge funds and other institutional investors have recently modified their holdings of the company. Cromwell Holdings LLC raised its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after purchasing an additional 170 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after buying an additional 335 shares during the last quarter. Venturi Wealth Management LLC lifted its position in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC boosted its stake in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after acquiring an additional 323 shares in the last quarter. Finally, City State Bank acquired a new position in shares of Henry Schein during the 4th quarter valued at about $55,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.